Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares fell 7.7% during trading on Wednesday . The stock traded as low as GBX 1.43 and last traded at GBX 1.43. 20,000 shares traded hands during trading, a decline of 98% from the average session volume of 1,206,483 shares. The stock had previously closed at GBX 1.55.
Cizzle Biotechnology Price Performance
The firm has a market cap of £5.67 million, a PE ratio of -4.47 and a beta of 0.38. The company’s 50 day moving average price is GBX 1.62 and its 200 day moving average price is GBX 1.55.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last announced its quarterly earnings data on Tuesday, September 30th. The company reported GBX (0.09) earnings per share (EPS) for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- GOLD ALERT
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
